NDC 72763-201

Tavaborole

Tavaborole

Tavaborole is a Topical Liquid in the Human Prescription Drug category. It is labeled and distributed by Estreno Pharma, Llc. The primary component is Tavaborole.

Product ID72763-201_e6c4d2f8-070c-4a81-9242-f2edca9b846f
NDC72763-201
Product TypeHuman Prescription Drug
Proprietary NameTavaborole
Generic NameTavaborole
Dosage FormLiquid
Route of AdministrationTOPICAL
Marketing Start Date2021-02-04
Marketing CategoryANDA / ANDA
Application NumberANDA211963
Labeler NameEstreno Pharma, LLC
Substance NameTAVABOROLE
Active Ingredient Strength44 mg/mL
Pharm ClassesOxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72763-201-10

1 BOTTLE in 1 CARTON (72763-201-10) > 10 mL in 1 BOTTLE
Marketing Start Date2021-02-04
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tavaborole" or generic name "Tavaborole"

NDCBrand NameGeneric Name
0574-0157TavaboroleTavaborole
21922-020TavaboroleTAVABOROLE topical solution, 5%
51672-1397TAVABOROLETAVABOROLE
51862-690tavaboroletavaborole
62332-467TavaboroleTavaborole
63629-8704TavaboroleTavaborole
68180-958TavaboroleTavaborole
69097-686TAVABOROLETAVABOROLE
69238-1657TavaboroleTavaborole
71589-010TAVABOROLETAVABOROLE
72763-201TavaboroleTavaborole
10337-905KerydinTavaborole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.